InsidersTradesSigma
인투셀 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 인투셀 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 인투셀 has recorded 12 reports. The latest transaction was reported on 2 February 2026 (Purchase). Among the most active insiders: 서영석. Every trade is free.
12
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 February 2026
Declarations12 total
861,587 sharesKRXDART:20250529000443
12 of 12 declarations
About 인투셀
인투셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for disease treatment.